
Congress trades
Bruker Corporation (BRKR)
NASDAQ · Healthcare · 13 congress trades · last filed 3 years ago
About Bruker Corporation
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Frank H. Laukien
- Employees
- 11,085
- Listed since
- Aug 4, 2000
- Market value
- $8.3B
- Price to earnings
- -
- Earnings per share
- -$0.47
- Dividend yield
- 0.37%
Earnings
6 reported quarters · next on Nov 2, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 4, 2026 | $0.49 | $0.38 | $838.5M | $853.6M | EPS beatRevenue miss |
| Q1 FY2026reported May 6, 2026 | $0.31 | $0.23 | $823.4M | $795.6M | EPS beatRevenue beat |
| Feb 12, 2026 | $0.59 | $0.65 | $977.2M | $962.3M | EPS missRevenue beat |
| Q3 FY2025reported Nov 3, 2025 | $0.60 | $0.33 | $860.5M | $964.6M | EPS beatRevenue miss |
| Q2 FY2025reported Aug 4, 2025 | $0.32 | $0.33 | $797.4M | $810.2M | EPS missRevenue miss |
| Q1 FY2025reported May 7, 2025 | $0.47 | $0.46 | $801.4M | $819.9M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 10, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Frank H. Laukien, Ph.D.Chairman, President and Chief Executive Officer | $977K | $1.6M | $2.1M | $4.7M |
| Mark R. Munch, Ph.D.Executive Vice President & President, Bruker NANO Grou | $738K | $792K | $648K | $2.2M |
| Gerald N. HermanExecutive Vice President and Chief Financial Officer | $644K | $866K | $500K | $2.0M |
| Juergen W. SregaPresident, Bruker CALID Group | $504K | $488K | $431K | $1.4M |
| Falko Busse, Ph.D.President, Bruker BioSpin Group | $545K | $311K | $565K | $1.4M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| FMR LLC | $1.2B | 20,237,425 | +25.7% | 13.30% |
| Orbis Allan Gray Ltd | $1.1B | 17,940,076 | 0.0% | 11.79% |
| Blackrock, Inc. | $686.5M | 11,407,332 | +2.0% | 7.50% |
| Pallas Capital Advisors LLC | $570.7M | 9,483,978 | +0.0% | 6.23% |
| Vanguard Portfolio Management LLC | $294.2M | 4,888,290 | +0.7% | 3.21% |
| Vanguard Capital Management LLC | $292.4M | 4,859,252 | +0.9% | 3.19% |
| Sculptor Capital LP | $278.3M | 4,625,000 | +41.4% | 3.04% |
| State Street Corp | $241.9M | 4,017,673 | +2.8% | 2.64% |
| Franklin Resources Inc | $194.3M | 3,229,337 | +10.6% | 2.12% |
| Sachem Head Capital Management LP | $175.4M | 2,915,000 | +100.0% | 1.92% |
| Edmond De Rothschild Holding S.A. | $169.9M | 2,823,178 | -15.9% | 1.85% |
| Dimensional Fund Advisors LP | $157.1M | 2,610,051 | +11.5% | 1.71% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Congress trades in BRKR
13 disclosures of 13 on record · median 31d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -20.2%S&P +85.1% · vs S&P 500 -105.2% | May 23, 2023 | Jun 12, 2023 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -1.2%S&P +91.9% · vs S&P 500 -93.2% | May 10, 2022 | Jun 10, 2022 | 31d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -20.1%S&P +81.6% · vs S&P 500 -101.7% | Jun 2, 2021 | Jul 16, 2021 | 44d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -21.2%S&P +84.0% · vs S&P 500 -105.3% | May 21, 2021 | Jun 17, 2021 | 27d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -21.4%S&P +82.2% · vs S&P 500 -103.6% | May 26, 2021 | Jun 17, 2021 | 22d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -21.4%S&P +82.2% · vs S&P 500 -103.6% | May 26, 2021 | Jun 17, 2021 | 22d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -18.1%S&P +88.3% · vs S&P 500 -106.5% | May 12, 2021 | Jun 17, 2021 | 36d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | +1.5%S&P +109.5% · vs S&P 500 -108.0% | Dec 14, 2020 | Jan 25, 2021 | 42d |
| Michael T. McCaulFiled late | Stock | Purchase | $15,001 - $50,000 | +61.9%S&P +203.3% · vs S&P 500 -141.4% | Apr 2, 2020 | May 18, 2020 | 46d |
| Michael T. McCaulFiled late | Stock | Purchase | $50,001 - $100,000 | +61.9%S&P +203.3% · vs S&P 500 -141.4% | Apr 2, 2020 | May 18, 2020 | 46d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +48.7%S&P +169.0% · vs S&P 500 -120.3% | Apr 14, 2020 | May 13, 2020 | 29d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +42.2%S&P +160.2% · vs S&P 500 -117.9% | Apr 29, 2019 | May 10, 2019 | 11d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | +99.8%S&P +271.7% · vs S&P 500 -171.9% | May 9, 2016 | Jun 16, 2016 | 38d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 9, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded BRKR?
Ro Khanna, Michael T. McCaul disclosed BRKR transactions in the filings shown here.
How quickly are BRKR trades disclosed?
Congressional disclosures took a median of 31 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
